Detalhe da pesquisa
1.
Probing the roles of SUMOylation in cancer cell biology by using a selective SAE inhibitor.
Nat Chem Biol
; 13(11): 1164-1171, 2017 Nov.
Artigo
em Inglês
| MEDLINE | ID: mdl-28892090
2.
Identification of microRNA biomarker candidates in urine and plasma from rats with kidney or liver damage.
J Appl Toxicol
; 37(3): 278-286, 2017 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-27397436
3.
The beagle dog MicroRNA tissue atlas: identifying translatable biomarkers of organ toxicity.
BMC Genomics
; 17: 649, 2016 08 17.
Artigo
em Inglês
| MEDLINE | ID: mdl-27535741
4.
Mutation of NRAS but not KRAS significantly reduces myeloma sensitivity to single-agent bortezomib therapy.
Blood
; 123(5): 632-9, 2014 Jan 30.
Artigo
em Inglês
| MEDLINE | ID: mdl-24335104
5.
Selective irreversible inhibition of a protease by targeting a noncatalytic cysteine.
Nat Chem Biol
; 7(1): 22-4, 2011 Jan.
Artigo
em Inglês
| MEDLINE | ID: mdl-21113170
6.
Quantitative proteomic analysis of cellular protein modulation upon inhibition of the NEDD8-activating enzyme by MLN4924.
Mol Cell Proteomics
; 10(11): M111.009183, 2011 Nov.
Artigo
em Inglês
| MEDLINE | ID: mdl-21873567
7.
Identification of a lung cancer cell line deficient in atg7-dependent autophagy.
Autophagy
; : 0, 2015 Jun 19.
Artigo
em Inglês
| MEDLINE | ID: mdl-26090719
8.
KRAS Genotype Correlates with Proteasome Inhibitor Ixazomib Activity in Preclinical In Vivo Models of Colon and Non-Small Cell Lung Cancer: Potential Role of Tumor Metabolism.
PLoS One
; 10(12): e0144825, 2015.
Artigo
em Inglês
| MEDLINE | ID: mdl-26709701
9.
Novel DNA damage checkpoints mediating cell death induced by the NEDD8-activating enzyme inhibitor MLN4924.
Cancer Res
; 73(1): 225-34, 2013 Jan 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-23100467